FLGT - Fulgent Corp Company Long-Term Debts

Graphic logo of Fulgent (FLGT)

The daily price chart for Fulgent Genetics, Inc. (FLGT) reflects the performance of a company that optimizes courier routes for the rapid delivery of genetic samples, supporting high network profitability. The current value of the metric is 0.01. Meanwhile, international conflicts and sanctions hinder global testing and create reagent shortages. Simultaneously, the business is developing AI sequencing algorithms and spatial biology tools, investing heavily in R&D.

Fulgent Genetics, Inc. (FLGT) - Company Long-Term Debts from 07/04/2022 to 10/30/2026

Fulgent Corp - analytical breakdowns and key metrics (FLGT)

- share price and expert price forecast:
Share Price fulgentgenetics.com|FLGT - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Fulgent Genetics|FLGT - Total Company Value
- book value of equity indicators:
Equity per Share Fulgent Genetics|FLGT - Book Capitalization|Market Capitalization to Book Value Ratio fulgentgenetics.com|FLGT - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Fulgent Genetics, Inc.|FLGT - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Fulgent|FLGT - Company Debts|Debts to Net Assets Fulgent Genetics|FLGT - Company Long-Term Debts|Short-Term Debt Volume Fulgent Genetics|Interim Coverage Ratio fulgentgenetics.com
- earnings and valuation multiples indicators:
FLGT - Net Profit
Analysis of all company metrics:FLGT fulgentgenetics.com
Manufactured products of Fulgent Genetics

This indicator aggregates all credit obligations with a maturity of more than one year, reflecting the long-term financing strategy and the level of debt load relative to equity. By analyzing the magnitude of the issuer's long-term liabilities, an investor assesses the ability of Fulgent Genetics, Inc. (FLGT) to scale its cloud-based genetic testing platform for the B2B sector without a critical risk of losing financial stability.

Who Fulgent Genetics, Inc. competes with

A: Company Long-Term Indebtedness|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN - Company Long-Term Debts|Cologuard (EXAS) - Company Long-Term Debt|Company Long-Term Indebtedness RVTY|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts anbio.com|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt QDEL (Quidel Corporation)|OPKO Corp - Company Long-Term Liabilities|CareDx (CDNA) - Long-Term Debt|MRVI - Company Long-Term Debt|Long-Term Debt Volume fluidigm.com LAB|CTKB: Company Long-Term Debts|OSUR - Long-Term Debt Volume|Company Long-Term Debt Exagen Inc|MDxHealth, Inc. (MDXH) - Long-Term Debt Volume|Company Long-Term Debts LUCD|PRE: Long-Term Liabilities|Insight Molecular Diagnostics Inc - Company Long-Term Liabilities|Company Long-Term Debts Trinity Biotech PLC TRIB|PRPH - Company Long-Term Debt|AIMD: Company Long-Term Debt|CODX: Company Long-Term Debts|Long-Term Indebtedness heartsciences.com HSCS|BMRA (Biomerica) - Company Long-Term Debts|Long-Term Debt Cardio Diagnostics Holdings, Inc. CDIO|Company Long-Term Debt Virax Biolabs Group Ltd (VRAX)|Bluejay Diagnostics Corp - Company Long-Term Indebtedness|Aspira Women's Health - Company Long-Term Liabilities|Amount of Long-Term Liabilities AXDX (acceleratediagnostics.com)|CNTG: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ENZ (Enzo Biochem, Inc.)|FRES: Company Long-Term Debts|Long-Term Indebtedness Genetic Technologies Limited GENE|ME (23andMe Holding Co.) - Company Long-Term Debts|Long-Term Debt psychemedics.com PMD